Drugs / Donor IL-15 stimulated NK cells
last change Jul 2021 re-read 3 minutes ago

Donor IL-15 stimulated NK cells

Cell therapy

Developed for
acute leukemia
Investigated by
Martín, José Luis Díez, M.D.

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT03669172 Nov 2017 → Jul 2021 acute leukemia Martín, José Luis Díez, M.D. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Donor IL-15 stimulated NK cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT03669172 ↗
Modality Cell therapy “NK cells incubated infusion (CD56 +, CD3) incubated ex vivo with IL-15 infusion” NCT03669172 ↗